The Apex Drug and Medical Device Regulator has strictly restricted the supply of critical Laboratory Consumables used in In-Vitro Fertilization (IVF) and Assisted Reproductive Technology (ART) exclusively to Registered Fertility Centers.

The Core Mandate
According to the circular (File No. MED/71/2026-eoffice, dated 23 June 2026), all media, reagents, and related consumables utilized in ART procedures—such as IVF and cryopreservation—are legally classified as medical devices. Consequently, they fall under the strict jurisdiction of the Medical Devices Rules, 2017, meaning any manufacturer or importer must possess a valid license to handle these products

The Problem Addressed

The Drugs Controller General of India (DCGI), Dr. Rajeev Singh Raghuvanshi, noted that the department received concerning reports of IVF media and consumables being supplied to Unregistered Medical Facilities.

The Risks: Operating through Unregistered Clinics poses serious threats to patient health and welfare. Unregulated environments can expose couples to infection risks, substandard laboratory protocols, and the potential misuse of sensitive reproductive technologies

The New Restriction

To enforce Safe and Ethical Reproductive Healthcare Practices, the CDSCO has ordered all stakeholders (manufacturers, importers, and suppliers) to strictly verify and ensure that these consumables are only distributed to centers registered under:

The Surrogacy (Regulation) Act, 2021

The Assisted Reproductive Technology (Regulation) Act, 2021

Impact

This directive marks a massive regulatory crackdown aimed at bringing transparency to India’s booming fertility market.

Medical experts have widely welcomed the move. Top gynecologists and IVF specialists note that because the quality and traceability of laboratory media directly impact embryonic development and treatment outcomes, cutting off supplies to unverified, non-compliant clinics is a necessary step to safeguard patient safety and build public trust.

đź”— Official References & Links

Leave a Reply

Your email address will not be published. Required fields are marked *